These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8768833)

  • 1. Hormonal responses during various phases of autoimmune adrenal failure: no evidence for 21-hydroxylase enzyme activity inhibition in vivo.
    Boscaro M; Betterle C; Volpato M; Fallo F; Furmaniak J; Rees Smith B; Sonino N
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2801-4. PubMed ID: 8768833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease.
    Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Greggio NA; Sanzari M; Tedesco F; Pedini B; Boscaro M; Presotto F
    J Clin Endocrinol Metab; 1997 Mar; 82(3):932-8. PubMed ID: 9062509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease.
    Betterle C; Volpato M; Rees Smith B; Furmaniak J; Chen S; Zanchetta R; Greggio NA; Pedini B; Boscaro M; Presotto F
    J Clin Endocrinol Metab; 1997 Mar; 82(3):939-42. PubMed ID: 9062510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early adrenal hypofunction in patients with organ-specific autoantibodies and no clinical adrenal insufficiency.
    Boscaro M; Betterle C; Sonino N; Volpato M; Paoletta A; Fallo F
    J Clin Endocrinol Metab; 1994 Aug; 79(2):452-5. PubMed ID: 8045962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure.
    Chen S; Sawicka J; Betterle C; Powell M; Prentice L; Volpato M; Rees Smith B; Furmaniak J
    J Clin Endocrinol Metab; 1996 May; 81(5):1871-6. PubMed ID: 8626850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report.
    De Bellis A A; Falorni A; Laureti S; Perrino S; Coronella C; Forini F; Bizzarro E; Bizzarro A; Abbate G; Bellastella A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):675-8. PubMed ID: 11158030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune Addison's disease--evidence for a role of steroid 21-hydroxylase autoantibodies in adrenal insufficiency.
    Furmaniak J; Kominami S; Asawa T; Wedlock N; Colls J; Smith BR
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1517-21. PubMed ID: 7962352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The natural history of autoimmune Addison's disease with a non-classical presentation: a case report and review of literature.
    Manso J; Pezzani R; Scarpa R; Gallo N; Betterle C
    Clin Chem Lab Med; 2018 May; 56(6):896-900. PubMed ID: 29478039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays.
    Betterle C; Volpato M; Pedini B; Chen S; Smith BR; Furmaniak J
    J Clin Endocrinol Metab; 1999 Feb; 84(2):618-22. PubMed ID: 10022426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies.
    De Bellis A; Bizzarro A; Rossi R; Paglionico VA; Criscuolo T; Lombardi G; Bellastella A
    J Clin Endocrinol Metab; 1993 Apr; 76(4):1002-7. PubMed ID: 8473373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimated risk for developing autoimmune Addison's disease in patients with adrenal cortex autoantibodies.
    Coco G; Dal Pra C; Presotto F; Albergoni MP; Canova C; Pedini B; Zanchetta R; Chen S; Furmaniak J; Rees Smith B; Mantero F; Betterle C
    J Clin Endocrinol Metab; 2006 May; 91(5):1637-45. PubMed ID: 16522688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to adrenal cytochrome P450 antigens in isolated Addison's disease and autoimmune polyendocrine syndrome type II.
    Seissler J; Schott M; Steinbrenner H; Peterson P; Scherbaum WA
    Exp Clin Endocrinol Diabetes; 1999; 107(3):208-13. PubMed ID: 10376448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid 21-hydroxylase autoantibodies: measurements with a new immunoprecipitation assay.
    Tanaka H; Perez MS; Powell M; Sanders JF; Sawicka J; Chen S; Prentice L; Asawa T; Betterle C; Volpato M; Smith BR; Furmaniak J
    J Clin Endocrinol Metab; 1997 May; 82(5):1440-6. PubMed ID: 9141530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brief report: adrenal autoimmunity in primary Sjögren's syndrome.
    Mavragani CP; Schini M; Gravani F; Kaltsas G; Moutsopoulos HM
    Arthritis Rheum; 2012 Dec; 64(12):4066-71. PubMed ID: 22933251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies.
    Betterle C; Scalici C; Presotto F; Pedini B; Moro L; Rigon F; Mantero F
    J Endocrinol; 1988 Jun; 117(3):467-75. PubMed ID: 3392502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of adrenal antibodies in Addison's disease among north Indian Caucasians.
    Nigam R; Bhatia E; Miao D; Yu L; Brozzetti A; Eisenbarth GS; Falorni A
    Clin Endocrinol (Oxf); 2003 Nov; 59(5):593-8. PubMed ID: 14616882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [21-hydroxylase autoantibodies as a marker of adrenal involvement in patients with autoimmune endocrinopathies].
    Degros V; Pons L; Ghulam A; Racadot A
    Ann Biol Clin (Paris); 1999; 57(6):705-9. PubMed ID: 10572219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease.
    Dal Pra C; Chen S; Furmaniak J; Smith BR; Pedini B; Moscon A; Zanchetta R; Betterle C
    Eur J Endocrinol; 2003 May; 148(5):565-70. PubMed ID: 12720541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease.
    Uibo R; Aavik E; Peterson P; Perheentupa J; Aranko S; Pelkonen R; Krohn KJ
    J Clin Endocrinol Metab; 1994 Feb; 78(2):323-8. PubMed ID: 8106620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.